William Annett
2017
In 2017, William Annett earned a total compensation of $1.2M as President and Chief Executive Officer at Oncocyte Corp, a 14% increase compared to previous year.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Option Awards | $740,276 |
| Salary | $397,308 |
| Other | $13,500 |
| Total | $1,191,084 |
Annett received $740.3K in option awards, accounting for 62% of the total pay in 2017.
Annett also received $40K in bonus, $397.3K in salary and $13.5K in other compensation.
Rankings
In 2017, William Annett's compensation ranked 8,138th out of 14,666 executives tracked by ExecPay. In other words, Annett earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,138 out of 14,666 | 45th |
Division Manufacturing | 3,065 out of 5,768 | 47th |
Major group Chemicals And Allied Products | 1,011 out of 2,074 | 51st |
Industry group Drugs | 794 out of 1,730 | 54th |
Industry In Vitro and In Vivo Diagnostic Substances | 27 out of 72 | 63rd |
Source: SEC filing on July 27, 2018.
Annett's colleagues
We found three more compensation records of executives who worked with William Annett at Oncocyte Corp in 2017.